this dose was increased by 1.5 g daily until ventricular premature depolarizations were suppressed by 75 percent or more , adverse drug effects occurred or a total daily dose of 7.5 g of sustained-release procainamide was reached .
C0151636
ventricular premature
C0033216
procainamide